pharma · Hypophosphatasia · Paroxysmal Nocturnal Hemoglobinuria
Alexion Europe SAS
Alexion Europe SAS patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
EU HQ
89 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- EU
- Employees
- 89
- Programs
- 33
- Drugs
- 40
- Patents
- 0
Alexion Europe SAS patents
0 pharmaceutical patents indexed for Alexion Europe SAS. 0 expire within 24 months.
Alexion Europe SAS has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
No patents matched
Frequently asked questions
How many patents does Alexion Europe SAS have?
0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Alexion Europe SAS patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.